Altimmune
ALT
#6943
Rank
NZ$0.98 B
Marketcap
NZ$9.44
Share price
1.20%
Change (1 day)
-39.19%
Change (1 year)

Earnings for Altimmune (ALT)

Earnings in 2025 (TTM): -NZ$0.15 Billion

According to Altimmune's latest financial reports the company's current earnings are NZ$0.02 Million. In 2024 the company made an earning of -NZ$0.17 Billion a decrease over its 2023 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Altimmune from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.15 Billion-10.64%
2024 -NZ$0.17 Billion7.48%
2023 -NZ$0.16 Billion4.17%
2022 -NZ$0.15 Billion-12.55%
2021 -NZ$0.17 Billion78.27%
2020 -NZ$93.6 Million164.65%
2019 -NZ$35.37 Million-54.59%
2018 -NZ$77.89 Million-12.95%
2017 -NZ$89.48 Million-164.04%
2016 NZ$0.13 B-2506.1%
2015 -NZ$5.81 Million-65.85%
2014 -NZ$17.01 Million-15.12%
2013 -NZ$20.04 Million146.72%
2012 -NZ$8.12 Million-16.07%
2011 -NZ$9.68 Million-76.1%
2010 -NZ$40.48 Million-8.89%
2009 -NZ$44.43 Million31.17%
2008 -NZ$33.87 Million549.91%
2007 -NZ$5.22 Million7.52%
2006 -NZ$4.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-NZ$31.21 Million-78.54%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.28 Billion 88.52%๐Ÿ‡บ๐Ÿ‡ธ USA